Corentec Co

Corentec Co Capital Expenditures

The Capital Expenditures (CapEx) of Corentec Co (104540.KQ) as of Oct 16, 2026 is -3.59 B KRW. In the previous year, Capital Expenditures (CapEx) was -6.13 B KRW — a change of -41.39% (higher).

Capital Expenditures

-3.59 BKRW

YoY

-41.39%

Last updated:

Capital Expenditures (CapEx) of Corentec Co is 2025 -3.59 B KRW. Capital Expenditures (CapEx) of Corentec Co was 2024 -6.13 B KRW. It decreases by -41.39% higher compared to the previous year.

The Corentec Co Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-3.95 B KRW
Jan 1, 2019
-3.30 B KRW
Jan 1, 2020
-6.40 B KRW
Jan 1, 2021
-8.39 B KRW
Jan 1, 2022
-6.15 B KRW
Jan 1, 2023
-11.83 B KRW
Jan 1, 2024
-6.13 B KRW
Jan 1, 2025
-3.59 B KRW
The Corentec Co Capital Expenditures history
YEARCapital ExpendituresYoY
-3.59 BKRW-41.39%
-6.13 BKRW-48.15%
-11.83 BKRW+92.21%
-6.15 BKRW-26.63%
-8.39 BKRW+31.14%
-6.40 BKRW+94.02%
-3.30 BKRW-16.58%
-3.95 BKRW-71.79%
-14.01 BKRW+17.25%
-11.95 BKRW+120.49%
-5.42 BKRW+2.60%
-5.28 BKRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Corentec Co Stock analysis

What does Corentec Co do? Corentec Co Ltd is a South Korean company headquartered in Cheonan, operating within the Health Care sector. The company went public on March 5, 2013, as indicated by its IPO date. Corentec specializes in the manufacture and sale of artificial articulations, focusing on orthopedic products. Its product portfolio includes hip systems such as primary systems, hemi-arthroplasty systems, and revision systems, featuring cementless and cemented femoral stems, acetabular cups, and bearing systems. The company also offers knee products, comprising primary fixed and mobile type systems, revision knee systems, and augment systems. Additionally, Corentec provides spine products, including pedicle screws and peek cages. The firm markets its hip products under the BENCOX brand, while knee and spine products are sold under the LOSPA and LOSPA IS brand names, respectively. Corentec serves both domestic and international markets, distributing its products globally. The company's website is www.corentec.com. Corentec's business model centers on developing and commercializing orthopedic solutions for joint replacement and spinal care, with a focus on quality and innovation in medical devices. The company's operations are based in Cheonan, South Korea, and it has maintained a presence in the health care industry since its IPO in 2013. Corentec Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Corentec Co stock

Capital Expenditures (CapEx) of Corentec Co is -3.59 B KRW in 2025.

Capital Expenditures (CapEx) of Corentec Co changed from -6.13 B KRW to -3.59 B KRW, representing a -41.39% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Corentec Co since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Corentec Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Corentec Co

All Key Metrics — Corentec Co